Upper-extremity venous thrombosis: A retrospective study about 160 cases

被引:11
作者
Drouin, L. [1 ]
Pistorius, M-A [1 ]
Lafforgue, A. [1 ]
N'Gohou, C. [2 ]
Richard, A. [1 ]
Connault, J. [1 ]
Espitia, O. [1 ]
机构
[1] CHU Nantes, Serv Med Interne, 1 Pl Alexis Ricordeau, F-44093 Nantes, France
[2] CHU Nantes, Dept Informat Med, 1 Pl Alexis Ricordeau, F-44093 Nantes, France
来源
REVUE DE MEDECINE INTERNE | 2019年 / 40卷 / 01期
关键词
Upper-extremity vein thrombosis; Pulmonary embolism; Venous catheter; DEEP-VEIN THROMBOSIS; INSERTED CENTRAL CATHETERS; RISK-FACTORS; CANCER-PATIENTS; THROMBOEMBOLISM; COMPLICATIONS; SCORE; ART;
D O I
10.1016/j.revmed.2018.07.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. - To describe the clinical features and etiologies of upper limb venous thrombosis (ULVT). Methods. - All patients with a clinically suspected ULVT, were included retrospectively from January to December 2016. Diagnosis of ULVT was based on doppler-ultrasonography. Clinical features, topography and symptomatic pulmonary embolism (PE) were analyzed. The sensitivity (Se), specificity (Sp), positive predictive value (PPV) and negative value (NPV) of clinical symptoms leading to ULVT suspicion were estimated by comparing patients with and without ULVT. Results. - Among 488 patients with a suspected ULVT, 160 were diagnosed with ULVT, including, 80 with deep venous thrombosis (DVT) and 80 with superficial venous thrombosis (SVT). Symptomatic PE was found in 2.5 % of cases (n =4). None of the clinical symptoms of ULVT had a sensitivity greater than 40 %. For DVT, presence of superior vena cava syndrome had a 100 % PPV, 71.6 % NPV and 100 % Sp. For SVT, the presence of an cord-like induration had a 85.7 % PPV, 75.3 % NPV and 98.4 % Sp. An endovenous device was present in 87.5 % of DVT and 97.5 % of SVT cases. Malignant hemopathy was found in 43.8 % and 31.3 % of cases of DVT and SVT, respectively. Sepsis and solid neoplasia were present in 25 % and 15 % of cases of ULVT, respectively. Peripherally inserted central catheter or implantable sites were present in 40 % and 17.5 % of DVT patients. No solid neoplasia, hematological malignancy or thrombophilia were diagnosed in patients with ULVT. Conclusion. - An endovenous device was involved in 92.5 % of cases of ULVT. The prevalence of symptomatic PE was low. Hematological malignancies, sepsis and neoplasia were the most common conditions present in patients with ULVT. (C) 2018 Societe Nationale Francaise de Medecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:9 / 15
页数:7
相关论文
共 28 条
[1]   Risk and prognosis of cancer after upper-extremity deep venous thrombosis: A population-based cohort study [J].
Adelborg, Kasper ;
Horvath-Puho, Erzsebet ;
Sundboll, Jens ;
Prandoni, Paolo ;
Ording, Anne ;
Sorensen, Henrik Toft .
THROMBOSIS RESEARCH, 2018, 161 :106-110
[2]   More on: the 'ART' behind the clot: solving the mystery [J].
Bauersachs, R. M. ;
Manolopoulos, K. ;
Hoppe, I. ;
Arin, M. J. ;
Schleussner, E. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (02) :438-439
[3]   Peripherally Inserted Central Catheters (PICCs) in Cancer Patients Under Chemotherapy: A Prospective Study on the Incidence of Complications and Overall Failures [J].
Bertoglio, Sergio ;
Faccini, Beatrice ;
Lalli, Luca ;
Cafiero, Ferdinando ;
Bruzzi, Paolo .
JOURNAL OF SURGICAL ONCOLOGY, 2016, 113 (06) :708-714
[4]   Clinical course of upper extremity deep vein thrombosis in patients with or without cancer: a systematic review [J].
Bleker, Suzanne M. ;
van Es, Nick ;
van Gils, Luuk ;
Daams, Joost G. ;
Kleinjan, Ankie ;
Bueller, Harry R. ;
Di Nisio, Marcello .
THROMBOSIS RESEARCH, 2016, 140 :S81-S88
[5]   Old and new risk factors for upper extremity deep venous thrombosis [J].
Blom, JW ;
Doggen, CJM ;
Osanto, S ;
Rosendaal, FR .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (11) :2471-2478
[6]   The "ART" of thromboembolism: A review of assisted reproductive technology and thromboembolic complications [J].
Chan, W. S. ;
Dixon, M. E. .
THROMBOSIS RESEARCH, 2008, 121 (06) :713-726
[7]   Venous thrombosis associated with peripherally inserted central catheters: A retrospective analysis of the Cleveland Clinic experience [J].
Chemaly, RF ;
de Parres, JB ;
Rehm, SJ ;
Adal, KA ;
Lisgaris, MV ;
Katz-Scott, DS ;
Curtas, S ;
Gordon, SM ;
Steiger, E ;
Olin, J ;
Longworth, DL .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (09) :1179-1183
[8]   The Michigan Risk Score to predict peripherally inserted central catheter-associated thrombosis [J].
Chopra, V. ;
Kaatz, S. ;
Conlon, A. ;
Paje, D. ;
Grant, P. J. ;
Rogers, M. A. M. ;
Bernstein, S. J. ;
Saint, S. ;
Flanders, S. A. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (10) :1951-1962
[9]   Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis [J].
Chopra, Vineet ;
Anand, Sarah ;
Hickner, Andy ;
Buist, Michael ;
Rogers, Mary A. M. ;
Saint, Sanjay ;
Flanders, Scott A. .
LANCET, 2013, 382 (9889) :311-325
[10]   A clinical prediction score for upper extremity deep venous thrombosis [J].
Constans, Joel ;
Salmi, Louis-Rachid ;
Sevestre-Pietri, Marie-Antoinette ;
Perusat, Sophie ;
Nguon, Monika ;
Degeilh, Maryse ;
Labarere, Jose ;
Gattolliat, Olivier ;
Boulon, Carine ;
Laroche, Jean-Pierre ;
Le Roux, Philippe ;
Pichot, Olivier ;
Qu, Isabelle ;
Conri, Claude ;
Bosson, Jean-Luc .
THROMBOSIS AND HAEMOSTASIS, 2008, 99 (01) :202-207